Deborah Stephens, DO, discusses patient-reported outcomes and quality of life reports from the SEQUOIA (zanubrutinib) and ...
Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...
Please provide your email address to receive an email when new articles are posted on . Use of an electronic patient-reported outcome-based program did not significantly reduce ED or inpatient visits ...
Bimekizumab is associated with significant improvements through 3 years across various patient-reported outcomes in those with plaque psoriasis.
An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...
SAN DIEGO, June 2, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained ...
Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
We comment on Dr. Dai et al.’s well-designed study in Journal of Clinical Oncology (1). This article reports the results of a randomized clinical trial comparing standard postoperative care with ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results